Confluence Advises Special Pathogens Laboratory in its sale to Pace Analytical

Confluence Advisors, LLC (“Confluence”) served as the exclusive advisor to Special Pathogens Laboratory (“SPL”) with respect to its sale to Pace Analytical Services, LLC (“Pace”), a portfolio company of Aurora Capital Partners (“Aurora”). SPL will operate as Pace’s flagship for national Legionella service offering.

Special Pathogens Laboratory provides evidence-based solutions to detect, control and remediate Legionella and other waterborne pathogens. The company is world-renowned and widely regarded as pioneering the market for Legionella testing, control, and prevention. SPL also provides consulting services for water safety & management plans and onsite water risk assessments. The Company operates out of a state-of-the-art 16,000 square foot testing laboratory in Pittsburgh, Pennsylvania.

“Special Pathogens Laboratory sets the industry standard for Legionella control and prevention,” states Pace® CEO, Eric Roman. “We look forward to welcoming Special Pathogens Laboratory and its highly qualified and dedicated team to Pace®. This acquisition reinforces our commitment to provide testing and analytical solutions to protect our environment and improve our health.”

Dr. Janet Stout, President and Founder of SPL shared,” We know Legionella, but when it came to how to transition SPL, we needed guidance from professionals. We found the absolute best partner with Confluence Advisors. They took the time to know us and our company. Their process was efficient and professional and exceeded our expectations every step of the way! With Confluence Advisors, we have secured a great future for our company and employees.”